Safety of HRX215 in Patients After Minor and Major Liver Resection

Clinical trial NCT06638502 · RECRUITING

Trial details

NCT number: NCT06638502
Sponsor: HepaRegeniX GmbH
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Liver Resection Colorectal Carcinoma Liver Metastases

Start date: 2025-05-06
Primary completion: 2027-07-31
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.